Purinergic P1 Receptor Antagonists
- Name
- Purinergic P1 Receptor Antagonists
- Accession Number
- DBCAT000508
- Description
Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS.
- Drugs
Drug Drug Description Theophylline A xanthine used to manage the symptoms of asthma, COPD, and other lung conditions caused by reversible airflow obstruction. Istradefylline A selective adenoside A2A receptor antagonist indicated in adjunct to levodopa and carbidopa for the treatment of Parkinson's Disease. Aminophylline A bronchodilator consisting of theophylline that is used for the treatment of bronchospasm due to asthma, emphysema and chronic bronchitis. Enprofylline Used in the management of symptoms of asthma. Also used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy. Naxifylline Investigated for use/treatment in congestive heart failure. Vipadenant Investigated for use/treatment in parkinson's disease. DPCPX CPX has been used in trials studying the treatment of Cystic Fibrosis. LJ-2698 Not Annotated - Drugs & Drug Targets